1例黑曲霉菌肺部感染患者临床抗感染治疗的药学监护  

Pharmaceutical Care for Clinical Anti-fungal Medication in a Patient with Aspergillus Niger Pulmonary Infection

作　　者：陈倩 张稷 杨航 张秀红 CHEN Qian;ZHANG Ji;YANG Hang;ZHANG Xiu-hong(Kunshan No.5 People's Hospital,Kunshan Jiangsu 215300,China;Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi Jiangsu 214023,China)

机构地区：[1]昆山市第五人民医院,江苏昆山215300 [2]南京医科大学附属无锡人民医院,江苏无锡214023

出　　处：《抗感染药学》2020年第12期1831-1834,共4页Anti-infection Pharmacy

基　　金：江苏省药学会-奥赛康医院药学基金(编号:A201729);江苏省药学会-天晴医院药学基金(编号:Q2019087)。

摘　　要：目的:探究临床药师参与黑曲霉菌肺部感染患者临床抗感染治疗中的作用。方法:临床药师参与1例肺移植术后经第2代测序技术(next-generation sequencing,NGS)检测为黑曲霉菌感染患者的抗感染治疗过程,协助医师调整抗感染治疗方案,并实施药学监护。结果:经两性霉素B治疗后,黑曲霉菌感染患者抗真菌治疗得到有效控制,肺部病灶趋于闭合,病情较为稳定。结论:临床药师参与黑曲霉菌感染患者临床抗真菌治疗,确保了患者用药的安全性及有效性。Objective:To explore the role of clinical pharmacists participating in the anti-infective medication for patient with Aspergillus Niger pulmonary infection.Methods:The clinical pharmacist participated in the process of antiinfective medication for a patient infected by Aspergillus niger,who was detected by next-generation sequencing,assisting physicians to adjust anti-infective medication plan,and its pharmaceutical care.Results:After amphotericin B treatment,the antifungal medication of Aspergillus Niger infective patient was effectively controlled;the pulmonary lesions tended to close,and the condition was relatively stable.Conclusion:Clinical pharmacists participated in clinical antifungal therapy for patients with Aspergillus Niger to ensure the safety and effectiveness of medication.

关 键 词：黑曲霉菌 肺部感染 两性霉素B 药学监护 

分 类 号：R969[医药卫生—药理学]